Trikha M - Search Results

1

CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo.

Trikha M, Zhou Z, Nemeth JA, Chen Q, Sharp C, Emmell E, Giles-Komar J, Nakada MT. Trikha M, et al. Int J Cancer. 2004 Jun 20;110(3):326-35. doi: 10.1002/ijc.20116. Int J Cancer. 2004. PMID: 15095296

2

Platelets and cancer: implications for antiangiogenic therapy.

Trikha M, Nakada MT. Trikha M, et al. Semin Thromb Hemost. 2002 Feb;28(1):39-44. doi: 10.1055/s-2002-20563. Semin Thromb Hemost. 2002. PMID: 11885024 Review.

3

Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.

Trikha M, Zhou Z, Timar J, Raso E, Kennel M, Emmell E, Nakada MT. Trikha M, et al. Cancer Res. 2002 May 15;62(10):2824-33. Cancer Res. 2002. PMID: 12019160

4

CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice.

Zaki MH, Nemeth JA, Trikha M. Zaki MH, et al. Among authors: trikha m. Int J Cancer. 2004 Sep 10;111(4):592-5. doi: 10.1002/ijc.20270. Int J Cancer. 2004. PMID: 15239138

5

Alphav integrin-targeted immunoconjugates regress established human tumors in xenograft models.

Chen Q, Millar HJ, McCabe FL, Manning CD, Steeves R, Lai K, Kellogg B, Lutz RJ, Trikha M, Nakada MT, Anderson GM. Chen Q, et al. Among authors: trikha m. Clin Cancer Res. 2007 Jun 15;13(12):3689-95. doi: 10.1158/1078-0432.CCR-07-0026. Clin Cancer Res. 2007. PMID: 17575234

6

Alpha-v integrins as therapeutic targets in oncology.

Nemeth JA, Nakada MT, Trikha M, Lang Z, Gordon MS, Jayson GC, Corringham R, Prabhakar U, Davis HM, Beckman RA. Nemeth JA, et al. Among authors: trikha m. Cancer Invest. 2007 Oct;25(7):632-46. doi: 10.1080/07357900701522638. Cancer Invest. 2007. PMID: 18027153 Review.

7

Role for beta3 integrins in human melanoma growth and survival.

Trikha M, Timar J, Zacharek A, Nemeth JA, Cai Y, Dome B, Somlai B, Raso E, Ladanyi A, Honn KV. Trikha M, et al. Int J Cancer. 2002 Sep 10;101(2):156-67. doi: 10.1002/ijc.10521. Int J Cancer. 2002. PMID: 12209993

8

Monoclonal antibodies as therapeutics in oncology.

Trikha M, Yan L, Nakada MT. Trikha M, et al. Curr Opin Biotechnol. 2002 Dec;13(6):609-14. doi: 10.1016/s0958-1669(02)00348-8. Curr Opin Biotechnol. 2002. PMID: 12482522 Review.

9

Inhibition of alpha(v)beta3 integrin reduces angiogenesis, bone turnover, and tumor cell proliferation in experimental prostate cancer bone metastases.

Nemeth JA, Cher ML, Zhou Z, Mullins C, Bhagat S, Trikha M. Nemeth JA, et al. Among authors: trikha m. Clin Exp Metastasis. 2003;20(5):413-20. doi: 10.1023/a:1025461507027. Clin Exp Metastasis. 2003. PMID: 14524530

10

7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesis.

Sassoli PM, Emmell EL, Tam SH, Trikha M, Zhou Z, Jordan RE, Nakada MT. Sassoli PM, et al. Among authors: trikha m. Thromb Haemost. 2001 May;85(5):896-902. Thromb Haemost. 2001. PMID: 11372685

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters